Synlett 2008(13): 1961-1964  
DOI: 10.1055/s-2008-1077970
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Synthesis of Novel 3-Oxopiperidin-2-ones from Methyl 2-Alkoxy-5-amino-2-pentenoates

Yves Dejaegher, Matthias D’hooghe, Norbert De Kimpe*
Department of Organic Chemistry, Faculty of Bioscience Engineering, Ghent University, Coupure Links 653, 9000 Ghent, Belgium
Fax: +32(9)2646243; e-Mail: norbert.dekimpe@UGent.be;
Further Information

Publication History

Received 5 May 2008
Publication Date:
15 July 2008 (online)

Abstract

Alkylamino-substituted 2-alkoxy-2-pentenoates, obtained through ring transformation of 4-(1-chloro-1-methylethyl)- or 4-(2-halo-1,1-dimethylethyl)azetidin-2-ones upon treatment with sodium methoxide in methanol, have been evaluated as substrates for the cyclization towards pyrrolidines and piperidines. Thus, a convenient approach for the transformation of methyl 2-alkoxy-5-amino-4,4-dimethyl-2-pentenoates into 5,5-dimethyl-3-oxopiperidin-2-ones is described utilizing an excess of concentrated sulfuric acid.

    References and Notes

  • 1a Page MI. Acc. Chem. Res.  1984,  17:  144 
  • 1b Page MI. Adv. Phys. Org. Chem.  1987,  23:  165 
  • 1c Page MI. Laws AP. Tetrahedron  2000,  56:  5631 
  • 1e The Organic Chemistry of β-Lactams   Georg GI. Wiley; New York: 1993. 
  • 1f Singh GS. D’hooghe M. De Kimpe N. Azetidines, Azetines, and Azetes: Monocyclic, In Comprehensive Heterocyclic Chemistry III, A Review of the Literature 1995-2007, Vol. 2   Katritzky A. Ramsden C. Scriven E. Taylor R. Elsevier; Oxford: 2008.  p.1-110  
  • 1g The Chemistry of β-Lactams   Page MI. Chapman and Hall; London: 1992. 
  • 1h Hart DJ. Ha DC. Chem. Rev.  1989,  89:  1447 
  • 2a Ojima I. Acc. Chem. Res.  1995,  28:  383 
  • 2b Ojima I. Delaloge F. Chem. Soc. Rev.  1997,  377 
  • 2c Singh GS. Tetrahedron  2003,  59:  7631 
  • 2d France S. Weatherwax A. Taggi AE. Lectka T. Acc. Chem. Res.  2004,  37:  592 
  • 2e Fisher JF. Meroueh SO. Mobashery S. Chem. Rev.  2005,  105:  395 
  • 2f Alcaide B. Almendros P. Aragoncillo C. Chem. Rev.  2007,  107:  4437 
  • 3a Lee HK. Chun JS. Pak CS. Tetrahedron Lett.  2001,  42:  3483 
  • 3b Lee HK. Chun JS. Pak CS. J. Org. Chem.  2003,  68:  2471 
  • 3c Lee HK. Chun JS. Pak CS. Tetrahedron  2003,  59:  6445 
  • 3d Kvrno L. Werder M. Hauser H. Carreira EM. J. Med. Chem.  2005,  48:  6035 
  • 3e Huguenot F. Brigaud T. J. Org. Chem.  2006,  71:  2159 
  • 3f Del Buttero P. Molteni G. Roncoroni M. Tetrahedron Lett.  2006,  47:  2209 
  • 3g Mishra RK. Coates CM. Revell KD. Turos E. Org. Lett.  2007,  9:  575 
  • 3h Alcaide B. Almendros P. Cabrero G. Ruiz MP.
    J. Org. Chem.  2007,  72:  7980 
  • 3i D’hooghe M. Dekeukeleire S. De Kimpe N. Org. Biomol. Chem.  2008,  6:  1190 
  • 4a Otaka A. Watanabe J. Yukimasa A. Sasaki Y. Watanabe H. Kinoshita T. Oishi S. Tamamura H. Fujii N. J. Org. Chem.  2004,  69:  1634 
  • 4b Kvaerno L. Ritter T. Werder M. Hauser H. Carreira EM. Angew. Chem. Int. Ed.  2004,  43:  4653 
  • 4c Dondoni A. Massi A. Sabbatini S. Bertolasi V. Adv. Synth. Catal.  2004,  346:  1355 
  • 4d Battaglia A. Guerrini A. Bertucci C. J. Org. Chem.  2004,  69:  9055 
  • 4e Ritter T. Kvaerno L. Werder M. Hauser H. Carreira EM. Org. Biomol. Chem.  2005,  3:  3514 
  • 4f Boros E. Bertha F. Czira G. Feller A. Fetter J. Kajtar-Peredy M. Simig G. J. Heterocycl. Chem.  2006,  43:  87 
  • 4g De Vitis L. Troisi L. Granito C. Pindinelli E. Ronzini L. Eur. J. Org. Chem.  2007,  356 
  • 5a Abbiati G. Rossi E. Tetrahedron  2001,  57:  7205 
  • 5b Durham TB. Miller MJ. J. Org. Chem.  2003,  68:  35 
  • 5c Hafez AM. Dudding T. Wagerle TR. Shah MH. Taggi AE. Lectka T. J. Org. Chem.  2003,  68:  5819 
  • 5d Gerona-Navarro G. Garcia-Lopez MT. Gonzalez-Muniz R. Tetrahedron Lett.  2003,  44:  6145 
  • 5e Basak A. Ghosh SC. Synlett  2004,  1637 
  • 5f Li X.-G. Kanerva LT. Adv. Synth. Catal.  2006,  348:  197 
  • 6 Khim S.-K. Nuss JM. Tetrahedron Lett.  1999,  40:  1827 
  • 7 Dejaegher Y. De Kimpe N. J. Org. Chem.  2004,  69:  5974 
  • 9a O’Hagan D. Nat. Prod. Rep.  2000,  17:  435 
  • 9b Weintraub PM. Sabol JS. Kane JM. Borcherding DR. Tetrahedron  2003,  59:  2953 
  • 9c Buffat MGP. Tetrahedron  2004,  60:  1701 
  • 10a Schreiber SL. Science  1991,  251:  283 
  • 10b Kahn K. Bruice TC. Bioorg. Med. Chem.  2000,  8:  1881 
  • 11a Lounasmaa M. Somersalo P. Tetrahedron  1986,  42:  1501 
  • 11b Jung A. Koch O. Ries M. Schaumann E. Synlett  2000,  92 
  • 11c Forns P. Fernández MM. Diez A. Rubiralta M. Cherrier MP. Bonin M. Quirion J.-C. Synthesis  1999,  258 
  • 12 Herdeis C. Bissinger G. Z. Naturforsch., B  1987,  42:  785 
  • 13a Wasserman HH. Ives JL. J. Org. Chem.  1985,  50:  3573 
  • 13b Edelstein F. Avramoff M. Shtacher G. Teitz Y. Eur. J. Med. Chem.  1980,  15:  566 
  • 13c Pinto DJP. Orwat MJ. Quan ML. Han Q. Galemmo RA. Amparo E. Wells B. Ellis C. He MY. Alexander RS. Rossi KA. Smallwood A. Wong PC. Luettgen JM. Rendina AR. Knabb RM. Mersinger L. Kettner C. Bai S. He K. Wexler RR. Lam PYS. Bioorg. Med. Chem. Lett.  2006,  16:  4141 
  • 13d Pinto DJP. Galemmo RA. Quan ML. Orwat MJ. Clark C. Li R. Wells B. Woerner F. Alexander RS. Rossi KA. Smallwood A. Wong PC. Luettgen JM. Rendina AR. Knabb RM. He K. Wexler RR. Lam PYS. Bioorg. Med. Chem. Lett.  2006,  16:  5584 
  • 16 Alcaide B. Almendros P. Cabrero G. Ruiz MP. J. Org. Chem.  2007,  72:  7980 
8

Representative Procedure; Synthesis of 1-Isopropyl-5,5-dimethylpiperidine-2,3-dione (6c): To (Z)-methyl 5-isopropylamino-2-methoxy-4,4-dimethyl-2-pentenoate (4c; 0.50 g, 2.2 mmol) [7] was added concd sulfuric acid (0.6 mL, 21.6 mmol) dropwise. The resulting homogeneous mixture was stirred at r.t. for 1 h and subsequently cooled to 0 ˚C. NaOH (1 M) was added cautiously dropwise until pH 10, the resulting aqueous phase was extracted with CH2Cl2 (3 × 5 mL) and the combined organic phases were dried (MgSO4). After filtration and evaporation of the solvent, crude 5,5-dimethyl-1-isopropylpiperidine-2,3-dione (6c) was purified by filtration over silica gel using EtOAc.
1-Isopropyl-5,5-dimethylpiperidine-2,3-dione (6c): yield: 50%. ¹H NMR (270 MHz, CDCl3): δ = 1.13 (s, 6 H, CqMe2), 1.18 (d, J = 6.6 Hz, 6 H, CHMe 2), 2.54 [s, 2 H, C(O)CH2], 3.22 (s, 2 H, NCH2Cq), 4.91 (sept, J = 6.6 Hz, 1 H, CHMe2). ¹³C NMR (68 MHz, CDCl3): δ = 18.94 (CHMe 2), 26.13 (Cq Me 2), 32.04 (C qMe2), 45.00 (CHMe2), 51.41 [C(O)CH2], 52.16 (NCH2Cq), 156.57, 191.84 (2 × C=O). IR (NaCl): 1726, 1658 (C=O) cm. MS (70 eV): m/z (%) = 183 (46) [M+], 168 (61) [M+ - Me], 154 (12), 140 (39), 126 (64), 112 (12), 99 (87), 98 (30), 97 (26), 85 (35), 84 (20), 83 (21), 77 (24), 72 (19), 71 (11), 70 (16), 69 (24), 59 (12), 58 (21), 57 (37), 56 (43), 55 (52). Anal. Calcd for C10H17NO2: C, 65.54; H, 9.35; N, 7.64. Found: C, 65.43; H, 9.51; N, 7.53.

14

Methyl 2-Hydroxy-4-isopropylamino-4-methyl-pentanoate (7a): yield: 86%; R f 0.05 (CH2Cl2-MeOH, 19:1). ¹H NMR (270 MHz, CDCl3): δ = 1.09, 1.11 (2 × d, J = 6.3 Hz, 6 H, Me 2CH), 1.19, 1.27 (2 × s, 6 H, CqMe2), 1.72 (d, J = 6.6 Hz, 2 H, CqCH2), 2.99 (sept, J = 6.3 Hz, 1 H, CHMe2), 3.75 (s, 3 H, OMe), 4.58 (t, J = 6.6 Hz, 1 H, OCH). ¹³C NMR (68 MHz, CDCl3): δ = 24.21, 28.88 (Cq Me 2), 25.79, 26.35 (CHMe 2), 42.64 (NCH), 43.11 (CHCH2), 51.59 (OMe), 54.32 (C qMe2), 69.52 (OCH), 174.39 (C=O). IR (NaCl): 3286, 1754 (OH, C=O) cm. MS (70 eV): m/z
(%) = no [M+], 201 (15), 188 (33) [M+ - Me], 186 (22), 171 (35), 170 (15), 156 (72), 144 (11), 138 (9), 128 (24), 115 (13), 114 (38), 102 (12), 100 (79), 99 (10), 98 (17), 96 (15), 86 (22), 85 (24), 84 (60), 83 (16), 74 (12), 72 (11), 71 (51), 70 (16), 68 (17), 58 (54), 57 (20), 56 (21), 55 (24).

15

1-Isopropyl-3-methoxy-5,5-dimethylpiperidin-2-one (12): yield: 80%; R f 0.40 (hexane-EtOAc, 3:2). ¹H NMR (270 MHz, CDCl3): δ = 1.02, 1.05 (2 × s, 6 H, CqMe2), 1.04, 1.06 (2 × d, J = 6.9 Hz, 6 H, Me 2CH), 1.62 [dd, J = 7.0, 13.0 Hz, 1 H, CqCH(H)], 1.88 [dd, J = 8.0, 13.0 Hz, 1 H, CqCH(H)], 2.79 [d, J = 12.0 Hz, 1 H, NCH(H)], 2.97 [d, J = 12.0 Hz, 1 H, NCH(H)], 3.57 (s, 3 H, OMe), 3.87 (dd, J = 8.0. 13.0 Hz, 1 H, OCH), 4.87 (sept, J = 6.9 Hz, 1 H, CHMe2). ¹³C NMR (68 MHz, CDCl3): δ = 19.19, 19.43 (CHMe 2), 26.04, 28.84 (Cq Me 2), 29.92 (C qCH2), 40.65 (Cq CH2), 43.41 (CHMe2), 51.30 (NCH2), 58.85 (OMe), 75.96 (OCH), 169.13 (C=O). IR (NaCl): 1646 (C=O) cm. MS (70 eV): m/z (%) = no [M+], 168 (100) [M+ - OMe], 155 (13), 153 (93), 140 (26), 139 (92), 138 (11), 125 (13), 123 (15), 112 (28), 111 (11), 98 (22), 97 (23), 85 (12), 84 (26), 83 (19), 82 (23), 81 (10), 80 (21), 72 (18), 70(11), 69 (10), 58 (24), 55 (37). Anal. Calcd for C11H21NO2: C, 66.29; H, 10.62; N, 7.03. Found: C, 66.13; H, 10.80; N, 6.88.